Cost of vaccination has risen 68 times in a decade, says report
Crisis looms as donor withdraws support to African countries; MSF urges GSK, Pfizer to slash vaccine price
Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth
Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
Strong medicine for weak drug patents
Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend
Make unethical drug trials a punishable offence, say experts
Current laws do not fix penalty if such practices are found
The natco-pfizer test
Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
The world needs pharmaceuticals from China and India to beat COVID-19
Chinese manufacturers make around 40% of all APIs used worldwide; China, India are the source of 75-80% of APIs imported to US
Big pharma’s dirty tricks
Drug giants from GSK, Abbott and Pfizer to Bayer have been fined for serious malpractices. They should be under close watch in India
Standing up to the US
India does not have to be apologetic about its patents law, which is fully compliant with WTO requirements on intellectual property protection
Drug trials: Irked NHRC issues notices to Centre and Andhra Pradesh government
Says respond else face action
US piles on the pressure
Patent law, domestic content rules in solar and ICT policy come under attack